1 Gibson CL，Attwood L. The impact of gender on

stroke pathology and treatment[J]. Neurosci Biobehav

Rev，2016，67：119-124.

2 Viscoli CM，Brass LM，Kernan WN，et al. A clinical

trial of estrogen-replacement therapy after ischemic

stroke[J]. N Engl J Med，2001，345：1243-1249.

3 Cai M，Ma YL，Qin P，et al. The loss of estrogen

efficacy against cerebral ischemia in aged postmenopausal

female mice[J]. Neurosci Lett，2014，558：

115-119.

4 Fan JZ，Yang L，Meng GL，et al. Estrogen improves

the proliferation and differentiation of hBMSCs

derived from postmenopausal osteoporosis through notch signaling pathway[J]. Mol Cell Biochem，2014，

392：85-93.

5 Dittmer S，Kovacs Z，Yuan SH，et al. TOX3 is a

neuronal survival factor that induces transcription

de pend i ng o n t he p r e s enc e of C ITED1 o r

phosphorylated CREB in the transcriptionally active

complex[J]. J Cell Sc，2011，124：252-260.

6 Pros sni tz ER，Ba r ton M. Est rogen biology：

new insights into GPER function and clinical

opportunities[J]. Mol Cell Endocrinol，2014，389：71-

83.

7 Murata T，Dietrich HH，Xiang C，et al. G proteincoupled

estrogen receptor agonist improves cerebral

microvascular function after hypoxia/reoxygenation

injury in male and female rats[J]. Stroke，2013，44：

779-785.

8 Lee E，Marta SW，Wang N，et al. GPR30 regulates

glutamate transporter GLT-1 expression in rat primary

astrocytes[J]. J Biol Chem，2012，287：26 817-26 828.

9 Gaignard P，Fréchou M，Schumacher M，et al.

Progesterone reduces brain mitochondrial dysfunction

after transient focal ischemia in male and female

mice[J]. J Cereb Blood Flow Metab，2016，36：562-568.

10 Rosar io ER，Pike CJ. Androgen regulation of

β-amyloid protein and the risk of Alzheimer's

disease[J]. Brain Res Rev，2008，57：444-453.

11 Yang SH，Liu R，Wen Y，et al. Neuroendocrine

mechanism for tolerance to cerebral ischemiareperfusion

injury in male rats[J]. J Neurobiol，2005，

62：341-351.

12 Malkin CJ，Pugh PJ，Morris PD，et al. Testosterone

replacement in hypogonadal men with angina

improves ischaemic threshold and quality of life[J].

Heart，2004，90：871-876.

13 Le e MN，Lee SH，Lee MY，et a l. Ef fect of

dihydrotestosterone on mouse embryonic stem cells

exposed to H2O2-induced oxidative stress[J]. J Vet Sci，

2008，9：247-256.

14 Pike CJ，Nguyen TVV，Ramsden M，et al. Androgen

cell signaling pathways involved in neuroprotective

actions[J]. Horm Behav，2008，53：693-705.

15 Lepore G，Gadau S，Peruffo A，et al. Aromatase

expression in cultured fetal sheep astrocytes after

nitrosative/oxidative damage[J]. Cell Tissue Res，2011，

344：407-413.

16 Selvamani A，Williams MH，Miranda RC，et al.

Circulating miRNA profiles provide a biomarker for

severity of stroke outcomes associated with age and

sex in a rat model[J]. Clin Sci，2014，127：77-89.

17 Zhou J，Zhang J. Identification of miRNA-21 and

miRNA-24 in plasma as potential early stage markers of acute cerebral infarction[J]. Mol Med Rep，2014，

10：971-976.

18 De GD，Stoop W，Sarre S，et al. Neuroprotective

efficacy of subcutaneous insulin-like growth factor-1

administration in normotensive and hypertensive rats

with an ischemic stroke[J]. Neuroscience，2013，250：

253-262.

19 Selvama n i A，Sathyan P，Mi randa RC，et a l.

An antagomi r to mic roRNA Let7f promotes

neuroprotection in an ischemic stroke model [J]. PLoS

One，2012，7：e32662.

20 O'Donnell MJ，Xavier D，Liu L，et al. Risk factors for

ischaemic and intracerebral haemorrhagic stroke in 22

countries (the INTERSTROKE study)：a case-control

study[J]. Lancet，2010，376：112-123.

21 Li B，Wang T，Lou Y，et al. Sex differences in

outcomes and associated risk factors after acute

ischemic stroke in elderly patients：a prospective

follow-up study[J]. J Stroke Cerebrovasc Dis，2015，

24：2277-2284.

22 Franconi F，Campesi I，Occhioni S，et al. Sex-gender

differences in diabetes vascular complications and

treatment[J]. Endocr Metab Immune Disord Drug

Targets，2012，12：179-196.

23 Zhao W，An Z，Hong Y，et al. Sex differences in

long-term outcomes among acute ischemic stroke

patients with diabetes in China[J]. Biol Sex Differ，

2015，6：1-10.

24 Coppens M，Eikelboom JW，Hart RG，et al. The

CHA2DS2-VASc score identifies those patients with

atrial fibrillation and a CHADS2 score of 1 who are

unlikely to benefit from oral anticoagulant therapy[J].

Eur Heart J，2013，34：170-176.

25 Wang Z，Li J，Wang C，et al. Gender differences

in 1-year clinical characteristics and outcomes after

stroke：results from the China National Stroke

Registry[J]. PLoS One，2013，8：e56459.

26 Shant si la E，Wol f f A，Lip GY，et al. Gender

differences in stroke prevention in atrial fibrillation in

general practice：using the GRASP-AF audit tool[J].

Int J Clin Pract，2015，69：840-845.

27 Haim M，Hoshen M，Reges O，et al. Prospective

nat ional study of the prevalence，incidence，

management and outcome of a large contemporary

cohort of patients with incident non-valvular atrial

fibrillation[J]. J Am Heart Assoc，2015，4：e001486.

28 Kuklina EV，Keenan NL，Callaghan WM，et al. Risk

of cardiovascular mortality in relation to optimal

low-density lipoprotein cholesterol combined with

hypert r iglyceridemia：is there a difference by

gender?[J]. Ann Epidemiol，2011，21：807-814.

29 Freiberg JJ，Tybjaerg-Hansen A，Jensen JS，et al.

Nonfasting triglycerides and risk of ischemic stroke in

the general population[J]. JAMA，2008，300：2142-

2152.

30 Petrea RE，Beiser AS，Seshadri S，et al. Gender

differences in stroke incidence and poststroke

disability in the Framingham heart study[J]. Stroke，

2009，40：1032-1037.

31 Wang J，Ning X，Yang L，et al. Sex differences in

trends of incidence and mortality of first-ever stroke

in rural Tianjin，China，from 1992 to 2012[J]. Stroke，

2014，45：1626-1631.

32 Ha che t O，Guenancia C，St amboul K，e t a l .

Frequency and predictors of stroke after acute

myocardial infarction specific aspects of in-hospital

and postdischarge events[J]. Stroke，2014，45：3514-

3520.

33 Naderi N，Masoomi H，Mozaffar T，et al. Patient

characteristics and comorbidities associated with

cerebrovascular accident following acute myocardial

infarction in the United States[J]. Int J Cardiol，2014，

175：323-327.

34 Morris AA，Pekarek A，Wittersheim K，et al. Gender

differences in the risk of stroke during support with

continuous-flow left ventricular assist device[J]. J

Heart Lung Transplant，2015，34：1570-1577.

35 Olivotto I，Maron MS，Adabag AS，et al. Genderrelated

differences in the clinical presentation and

outcome of hypertrophic cardiomyopathy[J]. J Am

Coll Cardiol，2005，46：480-487.

36 Peters SA，Huxley RR，Woodward M. Smoking as a

risk factor for stroke in women compared with men：

A systematic review and meta-analysis of 81 cohorts，

including 3 980 359 individuals and 42 401 strokes[J].

Stroke，2013，44：2821-2828.

37 Dormandy JA，Rutherford RB. Management of

peripheral arterial disease (PAD). TASC working

group. TransAtlantic Inter-Society Consensus (TASC)

[J]. J Vasc surg，2000，31：S1-S296.

38 Hiramoto JS，Katz R，Ix JH，et al. Sex differences

in the prevalence and clinical outcomes of subclinical

peripheral artery disease in the Health，Aging，and

Body Composition (Health ABC) study[J]. Vascular，

2014，22：142-148.

39 Wisman PP，Tangelder MJ，Van Hattum ES，et

al. Young women with PAD are at high risk of

cardiovascular complications[J]. Eur J Vasc Endovasc

Surg，2012，43：441-445.

40 Kim CK，Jung S，Yoon BW. Practical issues to

prevent stroke associated with non-valvular atrial

fibrillation[J]. J Stroke，2013，15：144-152.

41 Rietbrock S，Heeley E，Plumb J，et al. Chronic

at r ial f ibr illation：Incidence，prevalence，and

prediction of stroke using the Congestive heart failure，

Hypertension，Age>75，Diabetes mellitus，and prior

Stroke or transient ischemic attack (CHADS2) risk

stratification scheme[J]. Am Heart J，2008，156：57-

64.

42 Chao TF，Liu CJ，Chen SJ，et al. Atrial fibrillation

and the risk of ischemic stroke：does it still matter in

patients with a CHA2DS2-VASc score of 0 or 1?[J].

Stroke，2012，43：2551-2555.

43 Chao TF，Liu CJ，Wang KL，et al. Should atrial

fibrillation patients with 1 additional risk factor of

the CHA2DS2-VASc score (beyond sex) receive oral

anticoagulation?[J]. J Am Coll Cardiol，2015，65：

635-642.

44 Huang D，Anguo L，Yue WS，et al. Refinement of

ischemic stroke risk in patients with atrial fibrillation

and CHA2DS2-VASc score of 1[J]. Pacing Clin

Electrophysiol，2014，37：1442-1447.

45 Sumi S，Origasa H，Houkin K，et al. A modified

Essen stroke risk score for predicting recurrent

cardiovascular events：development and validation[J].

Int J Stroke，2013，8：251-257.

46 Johnston SC，Rothwell PM，Nguyen-Huynh MN，et

al. Validation and refinement of scores to predict very

early stroke risk after transient ischaemic attack[J].

Lancet，2007，369：283-292.

47 Vi l a nova MB，Maur i CG，Sanahuja J，e t a l .

Prediction of myocardial infarction in patients with

transient ischaemic a